See how top analysts and institutions rate ACN — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Wells Fargo | Initiated | Equal Weight | $251 | 2025-10-22 |
| Rothschild & Co Redburn | Downgrade | Buy → Neutral | $250 | 2025-09-03 |
| HSBC Securities | Initiated | Reduce | $240 | 2025-07-28 |
| Deutsche Bank | Resumed | Hold | 2025-07-17 | |
| Evercore ISI | Initiated | Outperform | $330 | 2025-07-17 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 2 | 12 | 11 | 1 | 0 |
| October 2025 | 2 | 12 | 11 | 1 | 0 |
| September 2025 | 3 | 12 | 8 | 1 | 0 |
| August 2025 | 2 | 13 | 7 | 1 | 1 |
The majority of institutional investors have issued a "Buy" rating for ACN, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
